{"id":451833,"date":"2021-03-05T10:03:32","date_gmt":"2021-03-05T15:03:32","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=451833"},"modified":"2021-03-05T10:03:32","modified_gmt":"2021-03-05T15:03:32","slug":"aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\/","title":{"rendered":"AQST Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm"},"content":{"rendered":"
\n

NEW YORK, March 05, 2021 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against\u00a0Aquestive Therapeutics, Inc. (“Aquestive” or “the Company”) (NASDAQ: AQST) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aquestive securities between December 2, 2019\u00a0and\u00a0September 25, 2020, inclusive (the “Class Period”).\u00a0Such investors are encouraged to join this case by visiting the firm\u2019s site: www.bgandg.com\/aqst<\/a>.<\/p>\n

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.<\/p>\n

The complaint alleges that throughout the Class Period, Defendants made materially false and\/or misleading statements, and failed to disclose that: (1) data included in the Libervant NDA submission showed a lower drug exposure level than desired for certain weight groups; (2) the foregoing significantly decreased the Libervant NDA’s approval prospects; (3) as a result, it was foreseeable that the FDA would not approve the Libervant NDA in its current form; and (4) as a result, the Company’s public statements were materially false and misleading at all relevant times.<\/p>\n

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm\u2019s site: www.bgandg.com\/aqst<\/a> or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Aquestive you have until April 30, 2021 to request that the Court appoint you as lead plaintiff.\u00a0 Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.<\/p>\n

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.\u00a0 Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.\u00a0 In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm\u2019s expertise includes general corporate and commercial litigation, as well as securities arbitration.\u00a0 \u00a0Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com<\/a><\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, March 05, 2021 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against\u00a0Aquestive Therapeutics, Inc. (“Aquestive” or “the Company”) (NASDAQ: AQST) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aquestive securities between December 2, 2019\u00a0and\u00a0September 25, 2020, inclusive (the “Class Period”).\u00a0Such investors are encouraged to join this case by visiting the firm\u2019s site: www.bgandg.com\/aqst. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the Class Period, Defendants made materially false and\/or misleading statements, and failed to disclose that: (1) data … <\/p>\n

Continue reading “AQST Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-451833","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAQST Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AQST Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, March 05, 2021 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against\u00a0Aquestive Therapeutics, Inc. (“Aquestive” or “the Company”) (NASDAQ: AQST) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aquestive securities between December 2, 2019\u00a0and\u00a0September 25, 2020, inclusive (the “Class Period”).\u00a0Such investors are encouraged to join this case by visiting the firm\u2019s site: www.bgandg.com\/aqst. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the Class Period, Defendants made materially false and\/or misleading statements, and failed to disclose that: (1) data … Continue reading "AQST Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-05T15:03:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Mjk0OCM0MDQ0NDA0IzIwMTc2OTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AQST Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm\",\"datePublished\":\"2021-03-05T15:03:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\\\/\"},\"wordCount\":374,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4Mjk0OCM0MDQ0NDA0IzIwMTc2OTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\\\/\",\"name\":\"AQST Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4Mjk0OCM0MDQ0NDA0IzIwMTc2OTA=\",\"datePublished\":\"2021-03-05T15:03:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4Mjk0OCM0MDQ0NDA0IzIwMTc2OTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4Mjk0OCM0MDQ0NDA0IzIwMTc2OTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AQST Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AQST Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\/","og_locale":"en_US","og_type":"article","og_title":"AQST Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm - Market Newsdesk","og_description":"NEW YORK, March 05, 2021 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against\u00a0Aquestive Therapeutics, Inc. (“Aquestive” or “the Company”) (NASDAQ: AQST) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aquestive securities between December 2, 2019\u00a0and\u00a0September 25, 2020, inclusive (the “Class Period”).\u00a0Such investors are encouraged to join this case by visiting the firm\u2019s site: www.bgandg.com\/aqst. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the Class Period, Defendants made materially false and\/or misleading statements, and failed to disclose that: (1) data … Continue reading \"AQST Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-05T15:03:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Mjk0OCM0MDQ0NDA0IzIwMTc2OTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AQST Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm","datePublished":"2021-03-05T15:03:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\/"},"wordCount":374,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Mjk0OCM0MDQ0NDA0IzIwMTc2OTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\/","name":"AQST Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Mjk0OCM0MDQ0NDA0IzIwMTc2OTA=","datePublished":"2021-03-05T15:03:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Mjk0OCM0MDQ0NDA0IzIwMTc2OTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4Mjk0OCM0MDQ0NDA0IzIwMTc2OTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aqst-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-aquestive-therapeutics-inc-investors-of-class-action-and-encourages-shareholders-to-contact-the-firm-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AQST Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/451833","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=451833"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/451833\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=451833"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=451833"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=451833"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}